Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on: February 23,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on:February 23,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on: May 27,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on:May 27,2024

Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P

Updated on: March 14,2024

Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P

Updated on:March 14,2024

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on: May 25,2024

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on:May 25,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on: March 25,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on:March 25,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on: March 25,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on:March 25,2024

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on: May 28,2024

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on:May 28,2024

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on: January 30,2024

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on:January 30,2024

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on: January 11,2024

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on:January 11,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024

Study demonstrates cellular immunity of 'comb-structured mRNA' as a novel cancer mRNA vaccine

by Innovation Center of NanoMedicineComb-structured mRNA and its immunological activities. Credit: Innovation Center of NanoMedicineA multi-institutional collaborative has developed a novel mRNA deriv

Updated on: February 20,2024

Study demonstrates cellular immunity of 'comb-structured mRNA' as a novel cancer mRNA vaccine

by Innovation Center of NanoMedicineComb-structured mRNA and its immunological activities. Credit: Innovation Center of NanoMedicineA multi-institutional collaborative has developed a novel mRNA deriv

Updated on:February 20,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024